New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2014
08:03 EDTSPNCSpectranetics price target raised to $30 from $24 at Stifel
Stifel increased its price target on Spectranetics after the company announced positive results from its EXCITE ISR clinical trial. The firm sees the results as a major milestone for Spectranetics and keeps a Buy rating on the shares.
News For SPNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
10:00 EDTSPNCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:04 EDTSPNCSpectranetics upgraded to Outperform from Market Perform at Northland
Northland upgraded Spectranetics to Outperform from Market Perform and maintained its $25 price target. The firm upgraded shares based on valuation and said the recent selloff seems overdone and expectations have been reset.
06:58 EDTSPNCSpectranetics upgraded to Outperform from Market Perform at Northland
Subscribe for More Information
July 24, 2015
09:31 EDTSPNCSpectranetics selloff on Q2 results warranted, says Northland
Northland views the post-earnings pullback in shares of Spectranetics as warranted and remains negative on the company's fundamentals. The lowered FY15 revenue "set off alarm bells" and the company's explanations for growth rates "provided a confusing picture," the firm tells investors in a research note.
08:57 EDTSPNCSpectranetics guidance is balance of downside/upside scenarios, says Canaccord
Canaccord believes Spectranetics' disappointing guidance will lead to a lower valuation for shares, but the firm sees it as a better balance of downside/upside scenarios. The firm said the company's best chance for redemption is better execution and does not believe its core business in VI and LM has vanished. Canaccord maintained its Buy rating but lowered its price target to $26.50 from $36 on Spectranetics shares.
06:59 EDTSPNCSpectranetics removed from Analyst Focus List at JPMorgan
Subscribe for More Information
July 23, 2015
16:08 EDTSPNCSpectranetics sees FY15 EPS (96c)-($1.07), consensus ($1.05)
Subscribe for More Information
16:06 EDTSPNCSpectranetics lowers FY15 revenue view to $240M-$250M from $258M
Subscribe for More Information
16:05 EDTSPNCSpectranetics reports Q2 EPS (22c), consensus (31c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use